Provided by Tiger Trade Technology Pte. Ltd.

Integra Lifesciences

13.55
+0.14001.04%
Volume:429.42K
Turnover:5.79M
Market Cap:1.06B
PE:-145.51
High:13.86
Open:13.86
Low:13.24
Close:13.41
52wk High:20.49
52wk Low:8.70
Shares:77.89M
Float Shares:58.67M
Volume Ratio:0.30
T/O Rate:0.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0931
EPS(LYR):-6.7400
ROE:-0.70%
ROA:2.82%
PB:1.01
PE(LYR):-2.01

Loading ...

Can Integra LifeSciences Holdings (IART) Be Cheap On Its Pediatric Registry Milestone?

Simply Wall St.
·
Oct 02

Integra LifeSciences Enrolls 100th Patient in AERA Pediatric Registry

MT Newswires Live
·
Sep 29

Integra Lifesciences Announces 100TH Patient Enrolled in Aera® Pediatric Registry

THOMSON REUTERS
·
Sep 29

Integra LifeSciences CLO, Corporate VP Lesha R. Shinn Files Initial Beneficial Ownership Statement

Reuters
·
Sep 29

Integra Lifesciences Updates Investor Presentation Amid Refinancing Plans

TIPRANKS
·
Sep 08

Integra LifeSciences Executives Present at Wells Fargo Healthcare Conference

Reuters
·
Sep 04

Integra LifeSciences Holdings (IART), Why Is It Getting Attention Now?

Simply Wall St.
·
Aug 22

How Earnings Turnaround And FX-Hit Outlook At Integra LifeSciences (IART) Has Changed Its Investment Story

Simply Wall St.
·
Aug 10

Integra Lifesciences (IART) Receives a Hold from BMO Capital

TIPRANKS
·
Jul 30

Wells Fargo Sticks to Their Hold Rating for Integra Lifesciences (IART)

TIPRANKS
·
Jul 30

Integra Lifesciences Holdings Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 29

GUIDANCE: (IART) Integra LifeSciences Expects 2026 Revenue Range $1.65B - $1.70B, vs. FactSet Est of $1.68B

MT Newswires Live
·
Jul 29

GUIDANCE: (IART) Integra LifeSciences Expects 2026 Adjusted EPS Range $2.40 to $2.50, vs. FactSet Est of $2.45

MT Newswires Live
·
Jul 29

Integra LifeSciences Q2 Revenue Slightly Beats, Adjusted EPS Tops Estimates

Reuters
·
Jul 29

Integra LifeSciences Q2 FY26 GAAP EPS Turns to Profit at $0.06; Revenue Rises 0.8% to $418.8 Million

Reuters
·
Jul 29

Integra Lifesciences Q2 Adjusted EPS USD 0.56 Vs. IBES Estimate USD 0.48

Reuters
·
Jul 29

Integra Lifesciences - Guides Q3 2026 Revenue $410 Mln-$425 Mln, Adj EPS $0.53-$0.61

THOMSON REUTERS
·
Jul 29

Integra Lifesciences - Reaffirms 2026 Organic Revenue Growth Guidance 0.8%-3.3% and Adj EPS $2.40-$2.50

THOMSON REUTERS
·
Jul 29

Integra Lifesciences Q2 EPS USD 0.06

THOMSON REUTERS
·
Jul 29

Integra Lifesciences Q2 Adjusted Ebitda USD 78.4 Million

THOMSON REUTERS
·
Jul 29